Literature DB >> 31548230

Cancer Genetic Counseling-Current Practice and Future Challenges.

Jaclyn Schienda1, Jill Stopfer1.   

Abstract

Cancer genetic counseling practice is rapidly evolving, with services being provided in increasingly novel ways. Pretest counseling for cancer patients may be abbreviated from traditional models to cover the elements of informed consent in the broadest of strokes. Genetic testing may be ordered by a cancer genetics professional, oncology provider, or primary care provider. Increasingly, direct-to-consumer testing options are available and utilized by consumers anxious to take control of their genetic health. Finally, genetic information is being used to inform oncology care, from surgical decision-making to selection of chemotherapeutic agent. This review provides an overview of the current and evolving practice of cancer genetic counseling as well as opportunities and challenges for a wide variety of indications in both the adult and pediatric setting.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31548230      PMCID: PMC7263095          DOI: 10.1101/cshperspect.a036541

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  135 in total

1.  Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.

Authors:  Elena M Stoffel; Pamela B Mangu; Stephen B Gruber; Stanley R Hamilton; Matthew F Kalady; Michelle Wan Yee Lau; Karen H Lu; Nancy Roach; Paul J Limburg
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

2.  High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer.

Authors:  Roland P Kuiper; Nicoline Hoogerbrugge; Marjolijn C Jongmans; Illja J Diets; Esmé Waanders; Marjolijn J Ligtenberg; Diede A G van Bladel; Eveline J Kamping; Peter M Hoogerbrugge; Saskia Hopman; Maran J Olderode-Berends; Erica H Gerkes; David A Koolen; Carlo Marcelis; Gijs W Santen; Martine J van Belzen; Dylan Mordaunt; Lesley McGregor; Elizabeth Thompson; Antonis Kattamis; Agata Pastorczak; Wojciech Mlynarski; Denisa Ilencikova; Anneke Vulto- van Silfhout; Thatjana Gardeitchik; Eveline S de Bont; Jan Loeffen; Anja Wagner; Arjen R Mensenkamp
Journal:  Clin Cancer Res       Date:  2018-01-19       Impact factor: 12.531

3.  "I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.

Authors:  Brittany C McGill; Claire E Wakefield; Janine Vetsch; Qishan Lim; Meera Warby; Alison Metcalfe; Jennifer A Byrne; Richard J Cohn; Katherine M Tucker
Journal:  Pediatr Blood Cancer       Date:  2019-04-22       Impact factor: 3.167

4.  Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study.

Authors:  Jennifer M Hoskovec; R L Bennett; M E Carey; J E DaVanzo; M Dougherty; S E Hahn; B S LeRoy; S O'Neal; J G Richardson; C A Wicklund
Journal:  J Genet Couns       Date:  2017-10-20       Impact factor: 2.537

5.  Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.

Authors:  Wassim Abida; Michael L Cheng; Joshua Armenia; Sumit Middha; Karen A Autio; Hebert Alberto Vargas; Dana Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Emily Carbone; Ethan S Barnett; Melanie Hullings; Jaclyn F Hechtman; Ahmet Zehir; Jinru Shia; Philip Jonsson; Zsofia K Stadler; Preethi Srinivasan; Vincent P Laudone; Victor Reuter; Jedd D Wolchok; Nicholas D Socci; Barry S Taylor; Michael F Berger; Philip W Kantoff; Charles L Sawyers; Nikolaus Schultz; David B Solit; Anuradha Gopalan; Howard I Scher
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

6.  Exome sequencing in neonates: diagnostic rates, characteristics, and time to diagnosis.

Authors:  Zöe Powis; Kelly D Farwell Hagman; Virginia Speare; Taylor Cain; Kirsten Blanco; Layla S Mowlavi; Emily M Mayerhofer; David Tilstra; Timothy Vedder; Jesse M Hunter; Marilyn Tsang; Lina Gonzalez; Gerald Vockley; Sha Tang
Journal:  Genet Med       Date:  2018-03-22       Impact factor: 8.822

Review 7.  The family history: the first genetic test, and still useful after all those years?

Authors:  Reed E Pyeritz
Journal:  Genet Med       Date:  2011-10-07       Impact factor: 8.822

8.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

9.  Understanding of BRCA VUS genetic results by breast cancer specialists.

Authors:  B K Eccles; E Copson; T Maishman; J E Abraham; D M Eccles
Journal:  BMC Cancer       Date:  2015-11-25       Impact factor: 4.430

Review 10.  Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review.

Authors:  Loredana Covolo; Sara Rubinelli; Elisabetta Ceretti; Umberto Gelatti
Journal:  J Med Internet Res       Date:  2015-12-14       Impact factor: 5.428

View more
  2 in total

Review 1.  Genetic Counseling and the Central Tenets of Practice.

Authors:  Barbara Biesecker
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

2.  What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?

Authors:  Ana Carolina Rathsam Leite; Daniele Assad Suzuki; Allan Anderson Lima Pereira; Natalia Polidorio Machado; Romualdo Barroso-Sousa; Tatiana Strava Correa; Fernanda Cesar Moura; Igor Alexandre Protzner Morbeck; Brenda Pires Gumz; Luiza Dib Batista Bugiato Faria; Gustavo Dos Santos Fernandes; Renata Lazari Sandoval
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.